Future of the Antifungals Market: Insights, Developments, and Strategic Overview

 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry.

Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025?

The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education.

The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, telemedicine and e-health, advancements in antifungal drug development, collaborations and partnerships.



Get your free sample today:

Global Antifungals Market Insights Report 2025 And Market Drivers To 2034 Sample



What Are The Key Factors Driving Growth In The Antifungals Market?

The increasing prevalence of fungal infections is expected to propel the growth of the antifungals market going forward. Fungal infections are diseases caused by the invasion and growth of fungi in or on the body. Fungi can affect various parts of the body, including the skin, nails, lungs, and mucous membranes. The increasing prevalence of fungal infections is due to factors such as the rising number of immunocompromised individuals, climate change creating more favorable environments for fungal growth, increased use of broad-spectrum antibiotics disrupting natural microbiomes, poor hygiene, urbanization, and the growing incidence of chronic conditions like diabetes that predispose individuals to fungal infections. Antifungals play a crucial role in treating fungal diseases by inhibiting the growth and reproduction of fungi, either by disrupting their cell wall or membrane, blocking essential enzymatic processes, or interfering with their ability to synthesize vital components, thereby reducing fungal load, alleviating symptoms, and preventing the spread of infection within the body. For instance, in September 2024, according to the International Society For Infectious Diseases, a US-based non-profit organization, an annual incidence of 6.5 million invasive fungal infections, associated with approximately 3.8 million mortalities, of which 2.5 million (68%; range 35-90%) are directly attributable to these infections. Therefore, the increasing incidence of fungal infections is expected to drive the antifungals market.



Emerging And High-Growth Segments In The Global Antifungals Market

The antifungals market covered in this report is segmented –



1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines

2) By Route of Administration: Oral, Parenteral, Topical

3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users



Subsegments:

1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin

2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole

3) By Polyenes: Amphotericin B, Nystatin

4) By Allylamines: Terbinafine, Naftifine



Antifungals Market Emerging Trends And Opportunities

Drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand their product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase revenues and stay competitive in the market.



Key Antifungals Company Insights:

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited



View the full antifungals market report here:

Global Antifungals Market Insights Report 2025 And Market Drivers To 2034



How Does Antifungals Market Growth Vary Across Major Regions?

North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa



Contact Us:



The Business Research Company



Market Research Reports



Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267



Email: info@tbrc.info





Follow Us On:



LinkedIn: The Business Research Company | LinkedIn